FDA Approves Vyvanse to Treat Binge-Eating Disorder
The Carlat Psychiatry Report, Volume 13, Number 4, April 2015
https://www.thecarlatreport.com/newsletter-issue/tcprv13n4/
Issue Links: Learning Objectives | Editorial Information
Topics: Eating Disorders | News of Note
Lisdexamfetamine (Vyvanse), a stimulant approved for treating kids and adults with ADHD, is the first drug approved by the US Food and Drug Administration (FDA) for treating adults with binge-eating disorder (BED).
You can't view details of this content, please login or buy subscription here